<http://schema.org/description>
"Drugmaker Sarepta Therapeutics Inc has entered into an exclusive licence agreement withBritain's Summit Therapeutics Plc to develop drugs totreat Duchenne muscular dystrophy (DMD), the companies said onTuesday."^^<http://www.w3.org/2001/XMLSchema#string>
<http://in.reuters.com/article/summit-sarepta-idINL3N1CA2CD>